Market Analysis — USC NORRIS CANCER HOSPITAL
CA market | 94 hospitals | HHI: nan (Competitive)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
94
Hospitals in Market
21,186
Total Beds
$36.4B
Market Revenue
Competitive
HHI: nan
None
Moat Rating (2/10)
#24
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share1.3%
Top 3 Concentration23.4%
Network Density0.44
Margin vs Market+12.7%
Bed Util vs Market-1.8%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The CA market is competitive — many players, value creation must come from operations not market power (HHI: nan).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full CA market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| CEDARS-SINAI MEDICAL CENTER | 908 | $3,923M | 10.8% | 4.3% |
| RONALD REAGAN UCLA | 446 | $2,621M | 7.2% | 2.1% |
| LOS ANGELES GENERAL MEDICAL CENTER | 596 | $1,958M | 5.4% | 2.8% |
| CITY OF HOPE NATIONAL MEDICAL CTR | 217 | $1,830M | 5.0% | 1.0% |
| HARBOR-UCLA MEDICAL CENTER | 369 | $1,540M | 4.2% | 1.7% |
| KFH - LOS ANGELES | 492 | $1,305M | 3.6% | 2.3% |
| KECK HOSPITAL OF USC | 301 | $1,109M | 3.0% | 1.4% |
| KFH - DOWNEY | 424 | $846M | 2.3% | 2.0% |
| SANTA MONICA UCLA MEDICAL CENTER | 281 | $836M | 2.3% | 1.3% |
| LAC OLIVE VIEW/UCLA MEDICAL CENTER | 225 | $755M | 2.1% | 1.1% |
Regional Payer Mix
■ Medicare 26%■ Medicaid 13%■ Commercial 61%